The current treatment for newly diagnosed glioblastoma consists of surgery followed by conventional radiotherapy (CRT) with concomitant and adjuvant chemotherapy. Hypofractionated radiation therapy (HFRT) has been investigated and it resulted feasible and safe. The aim of this study was to evaluate whether HFRT can be comparable to CRT.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2loLpyS
Παρασκευή 29 Δεκεμβρίου 2017
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A study using a new computer-aided detection (CAD) algorithm found breast cancers... Read more on AuntMinnieEurope.com Related Reading: ...
-
Dicyclohexyl phthalate (DCHP) is one of the phthalate plasticizers. The objective of the present study was to investigate the effects of DCH...
-
Health Promotion in the Community: Impact of Faith-Based Lay Health Educators in Urban NeighborhoodsAbstract Promoting wellness and providing reliable health information in the community present serious challenges. Lay health educators, al...
-
This study analyzes 24 climate extreme indices over North Thailand using observed data for daily maximum and minimum temperatures and total ...
-
: Intent to treat analysis p. 78 Sajith Babu Thavarool, Amit Tyagi, KN Harsha, Bhushan Kathuria, Nagendra Kadappa, Sithara Aravind, KM Asw...
-
Abstract Background Polycystic ovary syndrome (PCOS), a highly prevalent endocrinopathy is currently being designated as chronic low gra...
-
Abstract To characterize the anatomical connectivity of the prelemniscal radiations (Raprl), a white matter region within the posterior sub...
-
Ahead of print: Prävalenz und Risikofaktoren der felinen Hyperthyreose in einer Klinikpopulation ...Ziel: Die feline Hyperthyreose ist eine häufige Endokrinopathie bei älteren Katzen. In früheren Studien wurden unausgewogene Ernährung, Schi...
-
Publication date: April 2016 Source: European Journal of Cancer, Volume 57 Author(s): Tom Lesluyes, Gaëlle Pérot, Marine Roxane Largeau, C...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου